These effects, concurrently with the reduction of oxidative stress, lowering of TGFβ-1, and stimulation of Nrf2, led to the blocking of pathogenic pathways involved in the development of liver fibrosis, chronic inflammation, and collagen deposition. This evidence concerns the gene NFE2L2 and Hepatic fibrosis.